drugset / Trial / NCT00003832
Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of broxuridine in treating patients who are undergoing surgery for stage I or stage II prostate cancer. Broxuridine may help doctors determine the rate of growth of prostate tumors and help them plan effective treatment
Timeline
- Start
- 1999-07
- Primary completion
- 2002-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bromodeoxyuridine | Unknown | — | Intravenous |